TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/17/21 19:04 | 9/16/21 | MORF | Morphic Holding, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Linde Peter | MA | O | Chief Me | M.d | 0 | 0.00 | 0 | 10 | 999% | 11 | D | ||||||||||||||
9/17/21 19:04 | 9/16/21 | MORF | Morphic Holding, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Linde Peter | MA | O | Chief Me | S.d | -266 | 66.51 | 0 | -4 | -26 | 11 | D | ||||||||||||||
6/3/21 19:15 | 6/1/21 | MORF | Morphic Holding, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Linde Peter | MA | O | Chief Me | S | -299 | 49.85 | 0 | -6 | -57 | 5 | D | ||||||||||||||
3/17/21 19:07 | 3/16/21 | MORF | Morphic Holding, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Linde Peter | MA | O | Chief Me | M.d | 0 | 0.00 | 0 | 22 | 11 | D | |||||||||||||||
3/17/21 19:07 | 3/16/21 | MORF | Morphic Holding, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Linde Peter | MA | O | Chief Me | S.d | -768 | 64.02 | 0 | -12 | -53 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |